Depression Clinical Trial
— IMAGINE-POfficial title:
A Brief Intervention Targeting Anhedonia in Adolescents: a Feasibility Randomised Controlled Trial
Verified date | May 2022 |
Source | King's College London |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Depression is a common mental health problem that often begins during adolescence. Onset during adolescence can be disruptive to schoolwork and social relationships and if left untreated can lead to recurrence during adulthood, as well as the development of other mental health problems. Current treatments for depression (for both adults and young people) largely focus on reducing low mood and do not effectively tackle the other hallmark symptom of depression, anhedonia, which is characterised as a loss of enjoyment/ pleasure for previously enjoyed activities. Anhedonia is associated with increased risk of suicidality, so should be an important treatment target. Whilst some adult treatments are beginning to address anhedonia, little research has focussed on young people. It cannot be assumed that adult treatments will work identically in young people, particularly s their brains are still maturing compared to adults. The aim of this study is to complete a randomised feasibility trial, to see if it is possible to run a brief talking therapy for anhedonia in adolescent depression, by targeting one promising cognitive factor known to contribute to low positive affect: positive future mental imagery
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | June 30, 2024 |
Est. primary completion date | June 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 14 Years to 19 Years |
Eligibility | Inclusion Criteria: 1. Aged 14-19 2. Informed consent 3. Willing and able to engage in psychological therapy and complete assessments 4. scoring above clinical cut-off on the MFQ (33 items; clinical cut-off =20, and showing high symptoms of anhedonia, as measured by the SHAPS ( 14 items; abnormal level of hedonic tone>2). Exclusion Criteria: 1. Diagnosis of learning disability (but not difficulty e.g. dyslexia), diagnosis of Autism Spectrum Disorder, or significant head injury, neurological disorder or epilepsy 2. Unable to fluently communicate in spoken English 3. Unable to give informed consent 4. High levels of current risk 5. Currently receiving therapy (including school counselling) 6. Experiencing psychotic symptoms or depressed in the postnatal period (participants with co-morbid physical illness or non-psychotic disorders such as anxiety will not be excluded) |
Country | Name | City | State |
---|---|---|---|
United Kingdom | King's College London | London |
Lead Sponsor | Collaborator |
---|---|
King's College London | Mental Health Research UK |
United Kingdom,
Bridge JA, Birmaher B, Iyengar S, Barbe RP, Brent DA. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry. 2009 Jan;166(1):42-9. doi: 10.1176/appi.ajp.2008.08020247. Epub 2008 Dec 1. — View Citation
Burnett Heyes S, Lau JY, Holmes EA. Mental imagery, emotion and psychopathology across child and adolescent development. Dev Cogn Neurosci. 2013 Jul;5:119-33. doi: 10.1016/j.dcn.2013.02.004. Epub 2013 Mar 5. — View Citation
Dunn BD. Helping depressed clients reconnect to positive emotion experience: current insights and future directions. Clin Psychol Psychother. 2012 Jul-Aug;19(4):326-40. doi: 10.1002/cpp.1799. Epub 2012 Jun 5. — View Citation
Gabbay V, Johnson AR, Alonso CM, Evans LK, Babb JS, Klein RG. Anhedonia, but not irritability, is associated with illness severity outcomes in adolescent major depression. J Child Adolesc Psychopharmacol. 2015 Apr;25(3):194-200. doi: 10.1089/cap.2014.0105. Epub 2015 Mar 24. — View Citation
Giedd JN. The teen brain: insights from neuroimaging. J Adolesc Health. 2008 Apr;42(4):335-43. doi: 10.1016/j.jadohealth.2008.01.007. — View Citation
Holmes EA, Blackwell SE, Burnett Heyes S, Renner F, Raes F. Mental Imagery in Depression: Phenomenology, Potential Mechanisms, and Treatment Implications. Annu Rev Clin Psychol. 2016;12:249-80. doi: 10.1146/annurev-clinpsy-021815-092925. Epub 2016 Jan 15. — View Citation
Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004 May;10(2):307-12. doi: 10.1111/j..2002.384.doc.x. — View Citation
Pile V, Lau JYF. Looking forward to the future: Impoverished vividness for positive prospective events characterises low mood in adolescence. J Affect Disord. 2018 Oct 1;238:269-276. doi: 10.1016/j.jad.2018.05.032. Epub 2018 May 30. — View Citation
Pile V, Smith P, Leamy M, Blackwell SE, Meiser-Stedman R, Stringer D, Ryan EG, Dunn BD, Holmes EA, Lau JYF. A brief early intervention for adolescent depression that targets emotional mental images and memories: protocol for a feasibility randomised controlled trial (IMAGINE trial). Pilot Feasibility Stud. 2018 Jul 4;4:97. doi: 10.1186/s40814-018-0287-3. eCollection 2018. — View Citation
Pizzagalli DA. Depression, stress, and anhedonia: toward a synthesis and integrated model. Annu Rev Clin Psychol. 2014;10:393-423. doi: 10.1146/annurev-clinpsy-050212-185606. — View Citation
Zisook S, Lesser I, Stewart JW, Wisniewski SR, Balasubramani GK, Fava M, Gilmer WS, Dresselhaus TR, Thase ME, Nierenberg AA, Trivedi MH, Rush AJ. Effect of age at onset on the course of major depressive disorder. Am J Psychiatry. 2007 Oct;164(10):1539-46. doi: 10.1176/appi.ajp.2007.06101757. — View Citation
* Note: There are 11 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility outcome - 1: Uptake by schools | A percentage will be calculated for: the number of schools that express interest in the study divided the number of schools that do take part. | Through study completion, an average of 9 months | |
Primary | Feasibility outcome - 2: Uptake by participants | This will outcome will be assessed at the different stages of participant uptake:
the number of participants that completed the screen questionnaire divided by the number of students who received the screen questionnaire the number of participants that accepted the invitation to pre-assessment divided by the number of participants that were eligible for pre-assessment from the screen The number of participants randomised to intervention divided by the number of participants that completed the pre-assessment The number of participants that completed the post-assessment divided by the number of participants that were randomised to intervention |
Through study completion, an average of 9 months | |
Primary | Feasibility outcome - 3: Intervention completion | The number of participants successfully completing the intervention | Through study completion, an average of 9 months | |
Primary | Feasibility outcome - 4: Intervention drop-out | The number of participants that drop-out and the reasons for dropping out | Through study completion, an average of 9 months | |
Primary | Feasibility outcome - 5: Time Period | Time needed to collect and analyse data | Through study completion, an average of 9 months | |
Primary | Feasibility outcome - 6: Data completeness at pre-assessment | Data completeness for each questionnaire at pre-assessment | Through study completion, an average of 9 months | |
Primary | Feasibility outcome - 7: Missing Data at pre-assessment | Data missing and reasons for missing data at pre-assessment | Through study completion, an average of 9 months | |
Primary | Feasibility outcome - 8: Data completeness at post-assessment | Data completeness for each questionnaire at post-assessment | Through study completion, an average of 9 months | |
Primary | Feasibility outcome - 9: Missing Data at post-assessment | Data missing and reasons for missing data at post-assessment | Through study completion, an average of 9 months | |
Primary | Feasibility outcome - 10: Data completeness at follow-up assessment | Data completeness for each questionnaire at follow-up assessment | Through study completion, an average of 9 months | |
Primary | Feasibility outcome - 11: Missing Data at follow-up assessment | Data missing and reasons for missing data at follow-up assessment | Through study completion, an average of 9 months | |
Primary | Feasibility outcome - 12: Unexpected adverse effects | The number and nature of unexpected adverse effects will be recorded | Through study completion, an average of 9 months | |
Primary | Acceptability of the intervention - 1: Open questions for qualitative feedback of the programme | Qualitative questions on the feedback questionnaire:
What did you think of the programme? Was there anything that made you more likely or less likely to take part in the programme? How did you find completing the programme at school? Was there anything about the programme that you really liked? Was there anything about the training programme that you really didn't like? What was the most important thing about the programme for you? Would you recommend this to others who are experiencing difficulties with mood and self-esteem? If so why? Or why not? Is there anything else you'd like to say about this programme? |
Post-intervention (within 2 weeks of post intervention) | |
Primary | Acceptability of the intervention - 2: Satisfaction with the programme | Participants indicate how satisfied they were with the programme on a 5-point scale; minimum score: 1; maximum score 5. Higher scores indicate better outcome. | Post-intervention (within 2 weeks of post intervention) | |
Primary | Acceptability of the intervention - 3: Feedback on the number of sessions in the programme | Participants rate what they thought about the number of session on a 5-point scale. 1 = I would have liked 2+ less; 2= I would have liked 1-2 less; 3= I was happy with the number of sessions; 4= I would have liked 1-2 more; 5= I would have liked 2+ more. Minimum score: 1; maximum score 5. | Post-intervention (within 2 weeks of post intervention) | |
Primary | Acceptability of the intervention - 4: Extend the programme has helped | Participants rate the extent to which the programme helped them on a 5-point scale. Minimum score: 1; maximum score: 5; higher scores indicate better outcome. | Post-intervention (within 2 weeks of post intervention) | |
Primary | Acceptability of the intervention - 5: Recommend the programme to a friend | Participants rate if they would recommend the programme to a friend on a 5-point scale. 1= no, definitely not; 2= probably not; 3 = unsure; 4 = yes, probably; 5 = yes, definitely. Minimum score: 1; maximum score 5; higher scores indicate better outcome. | Post-intervention (within 2 weeks of post intervention) | |
Secondary | Mood and Feelings Questionnaire | A 33-item measure of low mood in young people rated on a 3-point Likert scale. Minimum score: 0; maximum score: 66; higher scores indicate worse outcome. | Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up | |
Secondary | Snaith-Hamilton Pleasure Scale | A measure of anhedonia, consisting of 14 items rated on a 4-point Likert scale. Minimum score: 0; maximum score: 56; higher scores indicate worse outcome. | Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up | |
Secondary | Positive and Negative Affect Schedule | A self-report measure of negative and positive affect and consists of 20-items (10 negative items, 10 positive items) rated on a 5-point Likert scale. On each subscale (negative and positive) minimum score: 10; maximum score: 50. Higher scores indicate greater negative affect and greater positive affect. | Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up | |
Secondary | The Prospective Imagery Task | A measure of imagery vividness. It has been adapted for use in young people by (Pile et al., 2018). Fourteen scenarios (7 positive and 7 negative) are presented to participants (e.g. "You will achieve something you wanted to"), who are asked to imagine each happening to them and then rate this mental image on a 5-point scale; 'No image at all' (score of 1) to 'Very clear and detailed' (score of 5). Higher scores indicate greater vividness of future imagery. | Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up | |
Secondary | Autobiographical Memory Task | A measure of memory specificity. Participants will be given an example of a specific memory and then asked to give a specific memory to ten cue words (five positive; five negative). | Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up | |
Secondary | Screen for Child Anxiety Related Disorders | A self-report measure of anxiety, consisting of 41 items rated on a 3-point Likert scale. Minimum score: 0; maximum score: 82; higher scores indicate worse outcome. | Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up | |
Secondary | Rosenberg Self Esteem Scale | A 10-item self-report measure of self-worth, rated on a 4-point Likert scale. Minimum score: 0; maximum score: 30; high scores indicate better outcome. | Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up | |
Secondary | Children's Response Style Questionnaire | A 25-item self report measure of response styles, rated on a 4-point scale; 'Almost never' (score of 0) to 'Almost always (score of 3). There are with three response style subscales: rumination, distraction and problem solving. Minimum scores on each subscale is 0. Maximum scores for each subscale: rumination: 39, distraction: 21, problem solving: 15. Higher scores indicate a greater tendency to engage in that response style. | Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up | |
Secondary | Self Compassion Scale | A 26-item self-report measure of self compassion, rated on a 5-point scale; 'Almost never' (a score of 1) to 'Almost always' (a score of 5). There are 6 subscales of self-compassion: self-kindness, self-judgement, common humanity, isolation, mindfulness and over identification. There is reverse scoring for subscales of self-judgement, isolation and over identification, as these indicate poorer self-compassion. The Self Compassion Scale is scored by computing a total self-compassion score. This total self-compassion score is calculated by first reverse scoring the negative subscales, then taking a mean of each subscale and then taking an average of the 6 subscale means). Self Compassion Scale Norms: 1.0-2.49 = low self-compassion; 2.5-3.5 = moderate self-compassion; 3.51-5.0 = high self-compassion. | Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up | |
Secondary | Child Revised Impact of Event Scale | A 13-item measure of post-traumatic stress symptoms in reference to a recent negative event, rated on a 4-point scale; Not at all (score of 0), Rarely (score of 1), Sometimes (score of 3), Often (score of 5). Minimum score: 0; Maximum score: 65. Higher scores indicate worse outcomes. | Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |